National political advisers have committed to accelerating China’s healthcare modernization following a pivotal meeting with President Xi Jinping in Beijing. The engagement, which occurred during a joint group meeting of the Chinese People’s Political Consultative Conference (CPPCC), has ignited renewed determination among health experts and policymakers to achieve the ambitious ‘Healthy China 2035’ vision.
President Xi emphasized that the forthcoming 15th Five-Year Plan period (2026-2030) represents a critical phase for establishing decisive progress toward nationwide health objectives. His address to advisers from the medical, health, welfare, and social security sectors highlighted the strategic importance of coordinated planning and rapid implementation.
Professor Jiang Jiandong, a CPPCC member and pharmaceutical sciences expert at the Chinese Academy of Medical Sciences, described the meeting as both inspirational and demanding. “President Xi’s profound concern for public health left a deep impression,” Jiang stated, outlining his commitment to developing a comprehensive pharmaceutical innovation ecosystem spanning from foundational research to clinical applications and commercial distribution.
The convergence of artificial intelligence with medical science emerged as a recurring theme. Jiang advocated for combining AI capabilities with biological intelligence to enhance drug design and data analysis while mitigating algorithmic limitations. This dual approach aims to advance treatments for cancer, metabolic diseases, and central nervous system disorders.
CPPCC member Wang Lu highlighted practical measures to bridge urban-rural health disparities, noting China’s current average life expectancy of 79.2 years and the target of reaching 80 years by 2030. Wang proposed expanding AI-assisted diagnostic platforms to empower rural clinics, potentially increasing their treatment capacity from several hundred to over 2,000 conditions while improving accuracy.
Innovative solutions for grassroots healthcare received significant attention. Ma Xiuzhen, a political advisory leader from Ningxia, proposed providing every resident with an AI-powered ‘intelligent family doctor’ at an estimated annual cost of less than 50 yuan per person. This digital solution would handle routine consultations, facilitate disease screening, and alleviate pressure on overworked community physicians.
The National Health Commission reported encouraging progress in primary care, with grassroots institutions handling 52.6% of all medical visits in 2025—a steadily increasing share that reflects improvements in tiered diagnosis systems.
The meeting also featured specialized contributions, including altitude sickness research from Xizang autonomous region expert Pasang Drolma, who reported successful prevention of altitude-related fatalities among workers on major infrastructure projects like the Qinghai-Xizang Railway. She expressed particular motivation from Xi’s emphasis on integrating traditional Chinese medicine with modern medical science.